Novavax (NVAX) Appoints Buck Phillips as CFO
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Join SI Premium – FREE
Novavax, Inc. (Nasdaq: NVAX) announced the appointment of Barclay A. "Buck" Phillips to the position of Senior Vice President and Chief Financial Officer, effective June 24, 2013. He will be responsible for managing Novavax' finance, treasury and communications functions.
Prior to joining Novavax, Mr. Phillips was Senior Vice President and Chief Financial Officer of Micromet, Inc. which was acquired by Amgen in 2012. Previously, he was Managing Director of Vector Fund Management and a Biotechnology Analyst and Director of Venture Investments at Invesco Funds Group, Inc.
Prior to joining Novavax, Mr. Phillips was Senior Vice President and Chief Financial Officer of Micromet, Inc. which was acquired by Amgen in 2012. Previously, he was Managing Director of Vector Fund Management and a Biotechnology Analyst and Director of Venture Investments at Invesco Funds Group, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Graphic Packaging elects Larry Venturelli as board chairman
- Guaranteed Rate Affinity names Charity Moreland VP of national builder unit
- Viking Therapeutics names Hubert Chen as chief medical officer
Create E-mail Alert Related Categories
Management ChangesRelated Entities
Amgen/MicrometSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
